A detailed history of 325 Capital LLC transactions in Biote Corp. stock. As of the latest transaction made, 325 Capital LLC holds 4,548,127 shares of BTMD stock, worth $27.1 Million. This represents 13.05% of its overall portfolio holdings.

Number of Shares
4,548,127
Previous 3,766,666 20.75%
Holding current value
$27.1 Million
Previous $28.1 Million 9.8%
% of portfolio
13.05%
Previous 12.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.33 - $8.36 $4.17 Million - $6.53 Million
781,461 Added 20.75%
4,548,127 $25.4 Million
Q2 2023

Aug 14, 2023

BUY
$5.27 - $6.9 $9.49 Million - $12.4 Million
1,800,000 Added 91.53%
3,766,666 $25.5 Million
Q1 2023

May 15, 2023

BUY
$3.14 - $6.19 $6.18 Million - $12.2 Million
1,966,666 New
1,966,666 $12.2 Million

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $45.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track 325 Capital LLC Portfolio

Follow 325 Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 325 Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on 325 Capital LLC with notifications on news.